| # | Drug | Count |
|---|---|---|
| 0 | ESTRADIOL | 4 |
| 1 | ESTRADIOL GEL 0.1% | 4 |
| 2 | ESTRADIOL TRANSDERMAL | 4 |
| 3 | ESTRADIOL, | 4 |
| 4 | ACETAMINOPHEN | 3 |
| 5 | AZELASTINE | 3 |
| 6 | AZELASTINE HYDROCHLORIDE | 3 |
| 7 | NAPROXEN | 3 |
| 8 | NAPROXEN SODIUM | 3 |
| 9 | TERIFLUNOMIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SAFINAMIDE MESYLATE | 1 | 0.0007 |
| 1 | CEFADROXIL | 1 | 0.0005 |
| 2 | PATISIRAN | 1 | 0.0004 |
| 3 | ALOGLIPTIN | 1 | 0.0003 |
| 4 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 5 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN | 1 | 0.0003 |
| 6 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 1 | 0.0002 |
| 7 | GLUTAMINE | 1 | 0.0002 |
| 8 | IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) | 1 | 0.0002 |
| 9 | AMANTADINE HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 3 | Barbiturate [EPC] | 1 | 0.0001 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 5 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 6 | RNA Synthetase Inhibitor Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Pyrimidine Synthesis Inhibitor [EPC] | 3 | 0.0001 |
| 8 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 9 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |